<p>瑞士銀行集團在最近向證券交易委員會提交的 13F 表格中表示，在第四季度將其在 RLI 公司的股份（紐約證券交易所代碼：RLI - 免費報告）增加了 8.7%。該機構投資者在此期間額外購買了 48,563 股後，持有 607,176 股該保險提供商的股票。瑞士銀行集團在最近的報告期末持有約 0.66% 的 RLI 股份，價值 38,847,000 美元。</p>
<ul>
<li>3 只抗衰退股票：低貝塔、高利潤、低債務</li>
</ul>
<p>其他幾家對沖基金也調整了對 RLI 的持股。加拿大皇家銀行在第一季度將其在 RLI 的股份增加了 115.1%。加拿大皇家銀行目前持有 56,386 股該保險提供商的股票，價值 4,529,000 美元，此前在上個季度額外購買了 30,170 股。高盛集團在第一季度將其在 RLI 的股份增加了 110.8%。高盛集團目前持有 185,504 股該保險提供商的股票，價值 14,902,000 美元，此前在上個季度額外購買了 97,501 股。Empowered Funds LLC 在第一季度將其在 RLI 的股份增加了 472.3%。Empowered Funds LLC 目前持有 29,177 股該保險提供商的股票，價值 2,344,000 美元，此前在上個季度額外購買了 24,079 股。EverSource Wealth Advisors LLC 在第二季度將其在 RLI 的股份增加了 46.2%。EverSource Wealth Advisors LLC 目前持有 1,559 股該保險提供商的股票，價值 113,000 美元，此前在上個季度額外購買了 493 股。最後，Amundi 在第二季度將其在 RLI 的股份增加了 16,550.0%。Amundi 目前持有 23,976 股該保險提供商的股票，價值 1,689,000 美元，此前在上個季度額外購買了 23,832 股。目前 77.89% 的股票由機構投資者和對沖基金持有。</p>
<h2>RLI 股票表現</h2>
<p>RLI 股票週五開盤價為 49.60 美元。該股票的 50 日移動平均線為 57.91 美元，200 日移動平均線為 60.35 美元。該公司的市值為 45.6 億美元，市盈率為 11.59，貝塔值為 0.42。RLI 公司的 1 年最低價為 48.66 美元，1 年最高價為 77.24 美元。</p>
<ul>
<li>不要忽視隱秘的寶石 Kinsale，隨着其漲至新高</li>
</ul>
<p>RLI（紐約證券交易所代碼：RLI - 獲取免費報告）最近於 4 月 22 日發佈了季度財報。該保險提供商報告每股收益（EPS）為 0.83 美元，超出分析師一致預期的 0.73 美元，超出幅度為 0.10 美元。RLI 的股本回報率為 17.72%，淨利潤率為 20.81%。該公司本季度的收入為 4.2387 億美元，而分析師預期為 5.6447 億美元。去年同期，該公司每股收益為 0.92 美元。該公司的收入同比增長了 4.0%。整體來看，研究分析師預測 RLI 公司今年將發佈 2.7 的每股收益。</p>
<h2>RLI 股息公告</h2>
<p>該公司最近宣佈了季度股息，已於 3 月 16 日（星期一）支付。3 月 2 日（星期一）的股東獲得每股 0.16 美元的股息。這相當於年化股息 0.64 美元，股息收益率為 1.3%。除息日期為 3 月 2 日（星期一）。RLI 的股息支付比率（DPR）目前為 14.95%。</p>
<h2>華爾街分析師預測增長</h2>
<ul>
<li>3 只波動性中型股在本財報季交易</li>
</ul>
<p>幾家券商最近對 RLI 發佈了報告。Citizens Jmp 在 1 月 23 日的研究報告中重申了對 RLI 股票的 “市場表現” 評級。富國銀行在 4 月 9 日的研究報告中將 RLI 的目標價從 59.00 美元下調至 55.00 美元，並對該股票設定了 “等權重” 評級。Keefe, Bruyette &amp; Woods 在 2 月 24 日的研究報告中將 RLI 的評級從 “適度買入” 上調至 “強力買入”。Zacks Research 在 4 月 2 日的研究報告中將 RLI 的評級從 “強烈賣出” 上調至 “持有”。最後，Weiss Ratings 在 4 月 2 日的研究報告中重申了對 RLI 股票的 “持有（c-）” 評級。一位研究分析師對該股票給予了強力買入評級，六位分析師給予了持有評級。根據 MarketBeat 的數據，該公司目前的共識評級為 “持有”，平均目標價為 61.50 美元。</p>
<p><strong>查看我們最新的 RLI 股票分析</strong></p>
<h2>關於 RLI</h2>
<p>（免費報告）</p>
<p>RLI 公司（NYSE：RLI）是一家專注於為企業和個人承保細分風險的專業財產和意外保險公司。公司總部位於伊利諾伊州皮奧里亞，通過獨立代理商和經紀人網絡運營，提供定製的保險解決方案。RLI 的做法強調嚴格的承保、針對性的產品開發和強大的客户服務，以維持盈利能力和長期增長。</p>
<p>RLI 成立於 1965 年，最初名為 Replacement Lens, Inc，最初為隱形眼鏡製造商提供保險，後來在 1980 年代轉向專業保險。</p>
<h2>另見</h2>
<ul>
<li>我們更看好的五隻股票超過 RLI</li>
</ul>
<p><strong>想看看其他對沖基金持有的 RLI 嗎？</strong> 訪問 HoldingsChannel.com 獲取 RLI 公司（NYSE：RLI - 免費報告）的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJMSQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJMSQ"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 RLI 嗎？</h2>
<p>在你考慮 RLI 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師正在悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 RLI 並不在名單上。</p>
<p>雖然 RLI 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

RLI保險

<p>瑞士銀行集團（UBS Group AG）在第四季度將其在 RLI 公司的股份增加了 8.7%，目前持有 607,176 股，價值約為 3880 萬美元。其他對沖基金也增加了他們的持股，皇家加拿大銀行（Royal Bank of Canada）增持了 115.1%，高盛（Goldman Sachs）增持了 110.8%。RLI 的股票開盤價為 49.60 美元，市值為 45.6 億美元，市盈率為 11.59。該公司報告了上一季度每股收益（EPS）為 0.83 美元，超出預期，並宣佈每股季度分紅為 0.16 美元。分析師對該公司的共識評級為 “持有”，平均目標價為 61.50 美元</p>

<p>UBS Group AG increased its stake in RLI Corp. (NYSE:RLI - Free Report) by 8.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 607,176 shares of the insurance provider's stock after acquiring an additional 48,563 shares during the period. UBS Group AG owned approximately 0.66% of RLI worth $38,847,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>瑞士銀行集團在最近向證券交易委員會提交的 13F 表格中表示，在第四季度將其在 RLI 公司的股份（紐約證券交易所代碼：RLI - 免費報告）增加了 8.7%。該機構投資者在此期間額外購買了 48,563 股後，持有 607,176 股該保險提供商的股票。瑞士銀行集團在最近的報告期末持有約 0.66% 的 RLI 股份，價值 38,847,000 美元。</p>
</div><ul>
<li>3 Recession-Resistant Stocks: Low Beta, High Margins, Low Debt</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只抗衰退股票：低貝塔、高利潤、低債務</li>
</ul>
</div><p>Several other hedge funds have also modified their holdings of RLI. Royal Bank of Canada raised its stake in shares of RLI by 115.1% in the first quarter. Royal Bank of Canada now owns 56,386 shares of the insurance provider's stock valued at $4,529,000 after acquiring an additional 30,170 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in shares of RLI by 110.8% in the first quarter. Goldman Sachs Group Inc. now owns 185,504 shares of the insurance provider's stock valued at $14,902,000 after acquiring an additional 97,501 shares in the last quarter. Empowered Funds LLC raised its stake in shares of RLI by 472.3% in the first quarter. Empowered Funds LLC now owns 29,177 shares of the insurance provider's stock valued at $2,344,000 after acquiring an additional 24,079 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in shares of RLI by 46.2% in the second quarter. EverSource Wealth Advisors LLC now owns 1,559 shares of the insurance provider's stock valued at $113,000 after acquiring an additional 493 shares in the last quarter. Finally, Amundi raised its stake in shares of RLI by 16,550.0% in the second quarter. Amundi now owns 23,976 shares of the insurance provider's stock valued at $1,689,000 after acquiring an additional 23,832 shares in the last quarter. 77.89% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他幾家對沖基金也調整了對 RLI 的持股。加拿大皇家銀行在第一季度將其在 RLI 的股份增加了 115.1%。加拿大皇家銀行目前持有 56,386 股該保險提供商的股票，價值 4,529,000 美元，此前在上個季度額外購買了 30,170 股。高盛集團在第一季度將其在 RLI 的股份增加了 110.8%。高盛集團目前持有 185,504 股該保險提供商的股票，價值 14,902,000 美元，此前在上個季度額外購買了 97,501 股。Empowered Funds LLC 在第一季度將其在 RLI 的股份增加了 472.3%。Empowered Funds LLC 目前持有 29,177 股該保險提供商的股票，價值 2,344,000 美元，此前在上個季度額外購買了 24,079 股。EverSource Wealth Advisors LLC 在第二季度將其在 RLI 的股份增加了 46.2%。EverSource Wealth Advisors LLC 目前持有 1,559 股該保險提供商的股票，價值 113,000 美元，此前在上個季度額外購買了 493 股。最後，Amundi 在第二季度將其在 RLI 的股份增加了 16,550.0%。Amundi 目前持有 23,976 股該保險提供商的股票，價值 1,689,000 美元，此前在上個季度額外購買了 23,832 股。目前 77.89% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>RLI Stock Performance</h2>
<div class="lb-trans"><h2>RLI 股票表現</h2>
</div><p>Shares of RLI stock opened at $49.60 on Friday. The stock's 50-day moving average is $57.91 and its two-hundred day moving average is $60.35. The firm has a market cap of $4.56 billion, a price-to-earnings ratio of 11.59 and a beta of 0.42. RLI Corp. has a 1 year low of $48.66 and a 1 year high of $77.24.</p>
<div class="lb-trans"><p>RLI 股票週五開盤價為 49.60 美元。該股票的 50 日移動平均線為 57.91 美元，200 日移動平均線為 60.35 美元。該公司的市值為 45.6 億美元，市盈率為 11.59，貝塔值為 0.42。RLI 公司的 1 年最低價為 48.66 美元，1 年最高價為 77.24 美元。</p>
</div><ul>
<li>Don't Overlook Hidden Gem Kinsale As Rallies To New Highs</li>
</ul>
<div class="lb-trans"><ul>
<li>不要忽視隱秘的寶石 Kinsale，隨着其漲至新高</li>
</ul>
</div><p>RLI (NYSE:RLI - Get Free Report) last released its quarterly earnings results on Wednesday, April 22nd. The insurance provider reported $0.83 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.73 by $0.10. RLI had a return on equity of 17.72% and a net margin of 20.81%.The firm had revenue of $423.87 million for the quarter, compared to analyst estimates of $564.47 million. During the same quarter last year, the company posted $0.92 earnings per share. The business's revenue was up 4.0% on a year-over-year basis. As a group, research analysts predict that RLI Corp. will post 2.7 EPS for the current year.</p>
<div class="lb-trans"><p>RLI（紐約證券交易所代碼：RLI - 獲取免費報告）最近於 4 月 22 日發佈了季度財報。該保險提供商報告每股收益（EPS）為 0.83 美元，超出分析師一致預期的 0.73 美元，超出幅度為 0.10 美元。RLI 的股本回報率為 17.72%，淨利潤率為 20.81%。該公司本季度的收入為 4.2387 億美元，而分析師預期為 5.6447 億美元。去年同期，該公司每股收益為 0.92 美元。該公司的收入同比增長了 4.0%。整體來看，研究分析師預測 RLI 公司今年將發佈 2.7 的每股收益。</p>
</div><h2>RLI Dividend Announcement</h2>
<div class="lb-trans"><h2>RLI 股息公告</h2>
</div><p>The business also recently declared a quarterly dividend, which was paid on Monday, March 16th. Stockholders of record on Monday, March 2nd were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date was Monday, March 2nd. RLI's dividend payout ratio (DPR) is presently 14.95%.</p>
<div class="lb-trans"><p>該公司最近宣佈了季度股息，已於 3 月 16 日（星期一）支付。3 月 2 日（星期一）的股東獲得每股 0.16 美元的股息。這相當於年化股息 0.64 美元，股息收益率為 1.3%。除息日期為 3 月 2 日（星期一）。RLI 的股息支付比率（DPR）目前為 14.95%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><ul>
<li>3 Volatile Mid-Caps to Trade This Earnings Season</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只波動性中型股在本財報季交易</li>
</ul>
</div><p>Several brokerages have recently issued reports on RLI. Citizens Jmp reiterated a &#34;market perform&#34; rating on shares of RLI in a research note on Friday, January 23rd. Wells Fargo &amp; Company cut their price target on RLI from $59.00 to $55.00 and set an &#34;equal weight&#34; rating on the stock in a research note on Thursday, April 9th. Keefe, Bruyette &amp; Woods upgraded RLI from a &#34;moderate buy&#34; rating to a &#34;strong-buy&#34; rating in a research note on Tuesday, February 24th. Zacks Research upgraded RLI from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Thursday, April 2nd. Finally, Weiss Ratings restated a &#34;hold (c-)&#34; rating on shares of RLI in a research note on Thursday, April 2nd. One research analyst has rated the stock with a Strong Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of &#34;Hold&#34; and an average target price of $61.50.</p>
<div class="lb-trans"><p>幾家券商最近對 RLI 發佈了報告。Citizens Jmp 在 1 月 23 日的研究報告中重申了對 RLI 股票的 “市場表現” 評級。富國銀行在 4 月 9 日的研究報告中將 RLI 的目標價從 59.00 美元下調至 55.00 美元，並對該股票設定了 “等權重” 評級。Keefe, Bruyette &amp; Woods 在 2 月 24 日的研究報告中將 RLI 的評級從 “適度買入” 上調至 “強力買入”。Zacks Research 在 4 月 2 日的研究報告中將 RLI 的評級從 “強烈賣出” 上調至 “持有”。最後，Weiss Ratings 在 4 月 2 日的研究報告中重申了對 RLI 股票的 “持有（c-）” 評級。一位研究分析師對該股票給予了強力買入評級，六位分析師給予了持有評級。根據 MarketBeat 的數據，該公司目前的共識評級為 “持有”，平均目標價為 61.50 美元。</p>
</div><p><strong>Check Out Our Latest Stock Analysis on RLI</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 RLI 股票分析</strong></p>
</div><h2>About RLI</h2>
<div class="lb-trans"><h2>關於 RLI</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>RLI Corporation NYSE: RLI is a specialty property and casualty insurance company focused on underwriting niche risks for businesses and individuals. Headquartered in Peoria, Illinois, the company operates through a network of independent agents and brokers, offering customized coverage solutions. RLI's approach emphasizes disciplined underwriting, targeted product development and strong customer service to maintain profitability and long-term growth.</p>
<div class="lb-trans"><p>RLI 公司（NYSE：RLI）是一家專注於為企業和個人承保細分風險的專業財產和意外保險公司。公司總部位於伊利諾伊州皮奧里亞，通過獨立代理商和經紀人網絡運營，提供定製的保險解決方案。RLI 的做法強調嚴格的承保、針對性的產品開發和強大的客户服務，以維持盈利能力和長期增長。</p>
</div><p>Founded in 1965 as Replacement Lens, Inc, RLI initially provided insurance for contact lens manufacturers before shifting its focus to specialty insurance in the 1980s.</p>
<div class="lb-trans"><p>RLI 成立於 1965 年，最初名為 Replacement Lens, Inc，最初為隱形眼鏡製造商提供保險，後來在 1980 年代轉向專業保險。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than RLI</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票超過 RLI</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding RLI?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RLI Corp. (NYSE:RLI - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對沖基金持有的 RLI 嗎？</strong> 訪問 HoldingsChannel.com 獲取 RLI 公司（NYSE：RLI - 免費報告）的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJMSQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=RLI"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in RLI Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 RLI 嗎？</h2>
</div><p>Before you consider RLI, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 RLI 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RLI wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師正在悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 RLI 並不在名單上。</p>
</div><p>While RLI currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 RLI 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

RLI Corp. $RLI Shares Bought by UBS Group AG

Market Beat

瑞銀集團

加拿大皇家銀行

高盛

Kinsale Capital

富國銀行

GS Hldg R

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

瑞銀集團 AG 購買了 RLI 保險公司$RLI 的股票